|
1
|
Director's Challenge Consortium for the
Molecular Classification of Lung Adenocarcinoma, . Shedden K,
Taylor JM, Enkemann SA, Tsao MS, Yeatman TJ, Gerald WL, Eschrich S,
Jurisica I, Giordano TJ, Misek DE, et al: Gene expression-based
survival prediction in lung adenocarcinoma: A multi-site, blinded
validation study. Nat Med. 14:822–827. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Minna JD, Roth JA and Gazdar AF: Focus on
lung cancer. Cancer cell. 1:49–52. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sun S, Schiller JH and Gazdar AF: Lung
cancer in never smokers-a different disease. Nat Rev Cancer.
7:778–790. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ling H, Fabbri M and Calin GA: MicroRNAs
and other non-coding RNAs as targets for anticancer drug
development. Nat Rev Drug Discov. 12:8472013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mattick JS and Makunin IV: Non-coding RNA.
Hum Mol Genet. 15 Suppl 1:R17–R29. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong
C, Huang Y, Hu X, Su F, Lieberman J and Song E: let-7 regulates
self renewal and tumorigenicity of breast cancer cells. Cell.
131:1109–1123. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kumar MS, Erkeland SJ, Pester RE, Chen CY,
Ebert MS, Sharp PA and Jacks T: Suppression of non-small cell lung
tumor development by the let-7 microRNA family. Proc Natl Acad Sci
USA. 105:3903–3908. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Faraoni I, Antonetti FR, Cardone J and
Bonmassar E: miR-155 gene: A typical multifunctional microRNA.
Biochim Biophys Acta. 1792:497–505. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nagano T and Fraser P: No-nonsense
functions for long noncoding RNAs. Cell. 145:178–181. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Prensner JR and Chinnaiyan AM: The
emergence of lncRNAs in cancer biology. Cancer Discov. 1:391–407.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Weakley SM, Wang H, Yao Q and Chen C:
Expression and function of a large non-coding RNA gene XIST in
human cancer. World J Surg. 35:1751–1756. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The rosetta stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wee LM, Flores-Jasso CF, Salomon WE and
Zamore PD: Argonaute divides its RNA guide into domains with
distinct functions and RNA-binding properties. Cell. 151:1055–1067.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y,
Chen N, Sun F and Fan Q: CREB up-regulates long non-coding RNA,
HULC expression through interaction with microRNA-372 in liver
cancer. Nucleic Acids Res. 38:5366–5383. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fan M, Li X, Jiang W, Huang Y, Li J and
Wang Z: A long non-coding RNA, PTCSC3, as a tumor suppressor and a
target of miRNAs in thyroid cancer cells. Exp Ther Med.
5:1143–1146. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sui J, Li YH, Zhang YQ, Li CY, Shen X, Yao
WZ, Peng H, Hong WW, Yin LH, Pu YP, et al: Integrated analysis of
long non-coding RNAassociated ceRNA network reveals potential
lncRNA biomarkers in human lung adenocarcinoma. Int J Oncol.
49:2023–2036. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sui J, Xu SY, Han J, Yang SR, Li CY, Yin
LH, Pu YP and Liang GY: Integrated analysis of competing endogenous
RNA network revealing lncRNAs as potential prognostic biomarkers in
human lung squamous cell carcinoma. Oncotarget. 8:65997–66018.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Edge S, Byrd DR, Compton CC, Fritz AG,
Greene F and Trotti A: AJCC Cancer Staging Handbook: From the AJCC
Cancer Staging Manual. 7th edition. Springer-Verlag; New York, NY:
2010
|
|
20
|
Robinson MD, McCarthy DJ and Smyth GK:
edgeR: A Bioconductor package for differential expression analysis
of digital gene expression data. Bioinformatics. 26:139–140. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Alizadeh AA, Gentles AJ, Alencar AJ, Liu
CL, Kohrt HE, Houot R, Goldstein MJ, Zhao S, Natkunam Y, Advani RH,
et al: Prediction of survival in diffuse large B-cell lymphoma
based on the expression of 2 genes reflecting tumor and
microenvironment. Blood. 118:1350–1358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Detterbeck FC, Boffa DJ and Tanoue LT: The
new lung cancer staging system. Chest. 136:260–271. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Suzuki K, Yokose T, Yoshida J, Nishimura
M, Takahashi K, Nagai K and Nishiwaki Y: Prognostic significance of
the size of central fibrosis in peripheral adenocarcinoma of the
lung. Anna Thorac Surg. 69:893–897. 2000. View Article : Google Scholar
|
|
25
|
Yanaihara N, Caplen N, Bowman E, Seike M,
Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, et
al: Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tay Y, Rinn J and Pandolfi PP: The
multilayered complexity of ceRNA crosstalk and competition. Nature.
505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Amer M, Elhefnawi M, El-Ahwany E, Awad AF,
Gawad NA, Zada S and Tawab FM: Hsa-miR-195 targets PCMT1 in
hepatocellular carcinoma that increases tumor life span. Tumour
Biol. 35:11301–11309. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fu MG, Li S, Yu TT, Qian LJ, Cao RS, Zhu
H, Xiao B, Jiao CH, Tang NN, Ma JJ, et al: Differential expression
of miR-195 in esophageal squamous cell carcinoma and miR-195
expression inhibits tumor cell proliferation and invasion by
targeting of Cdc42. FEBS Lett. 587:3471–3479. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Susluer Yilaz S, Avci Biray C, Dodurga Y,
Ozlem Dogan Sigva Z, Oktar N and Gunduz C: Downregulation of
miR-195 via cyclosporin A in human glioblastoma cells. J BUON.
20:1337–1340. 2015.PubMed/NCBI
|
|
30
|
Chabre O, Libe R, Assie G, Barreau O,
Bertherat J, Bertagna X, Feige JJ and Cherradi N: Serum miR-483-5p
and miR-195 are predictive of recurrence risk in adrenocortical
cancer patients. Endocr Relat Cancer. 20:579–594. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Provenzano PP, Inman DR, Eliceiri KW,
Knittel JG, Yan L, Rueden CT, White JG and Keely PJ: Collagen
density promotes mammary tumor initiation and progression. BMC Med.
6:112008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Feng Z and Levine AJ: The regulation of
energy metabolism and the IGF-1/mTOR pathways by the p53 protein.
Trends Cell Biol. 20:427–434. 2010. View Article : Google Scholar : PubMed/NCBI
|
